Indication intelligence, analysis and sector perception

RegMed Investors (RMi): April - a roller coaster month ends

May 1, 2020 3:20pm

At times of sharp market fluctuations, the sector tends to move in sync with markets, with the RegMed/cell and gene therapy market particularly impacted by trends.

The sector and markets fluctuated dramatically; not always looking to fundamental value but scary speculative moves generated by electronic trading i.e. algorithms fostered by incredible uncertainty sponsored by the many named coronavirus that has confused and muddled any sector or market expectation.

The coronavirus outbreak or COVID -19, Wuhan virus has transformed the U.S. and EU and Asia Pacific stock markets into a seemingly unending and sickening roller coaster ride which has proved hard for many investors to stomach and understand.

April at-a-glance:

Thursday (4/30) closed negative with 27 decliners, 7 advancer and 1 flat
Wednesday closed positive with 13 decliners, 22 advancer and 0 flat
Tuesday closed negative with 28 decliners, 7 advancer and 0 flat
Monday (4/27) closed positive with 11 decliners, 22 advancers and 2 flats

Friday closed positive with 6 decliners, 29 advancer and 0 flat
Thursday closed negative with 19 decliners, 16 advancer and 0 flat
Wednesday closed positive with 6 decliners, 29 advancer and 0 flat
Tuesday closed negative with 32 decliners, 3 advancer and 0 flat
Monday (4/20) closed positive with 10 decliners, 30 advancer and 0 flat

Friday closed positive with 6 decliners, 29 advancer and 0 flat
Thursday closed negative with 20 decliners, 14 advancer and 1 flat
Wednesday closed negative with 29 decliners, 6 advancer and 0 flats
Tuesday closed positive with 4 decliners, 31 advancer and 0 flats
Monday (4/13) closed negative with 19 decliners, 16 advancer and 0 flats

Friday was a market holiday
Thursday closed positive with 7 decliners, 28 advancer and 0 flat
Wednesday closed positive with 4 decliners, 30 advancer and 1 flat
Tuesday closed negative with 18 decliners, 17 advancer and 0 flats
Monday (4/6) closed positive with 2 decliners, 33 advancer and 0 flats

Friday closed negative with 23 decliners, 12 advancer and 0 flats
Thursday closed positive with 10 decliners, 23 advancer and 2 flats
Wednesday (4/1) closed negative with 31 decliners, 4 advancer and 0 flat

35 companies, 1 interpreter!

Insight, foresight and recommendation

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.